Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2020 | ESMO economic model for cancer medicines

Panos Kanavos • 21 Sep 2020
ESMO 2020
General

Panos Kanavos, PhD, London School of Economics and Political Science, London, UK, discusses the collaboration between ESMO and the London School of Economics and Political Science (LSE) looking at the ESMO economic model for cancer medicines. This study has assessed data from six countries looking at the economic value of cancer medicines and how decisions should be made for funding new treatments. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Related Videos

1:56
Phase I trial of trastuzumab deruxtecan and neratinib in HER2-altered tumors
Haeseong Park • 8 Apr 2024
2:45
Remaining challenges in treating solid tumors with CAR-Treg therapy
Leonardo Ferreira • 8 Apr 2024
2:01
Engineering chimeric antigen receptor regulatory T cells for treating cancer
Leonardo Ferreira • 8 Apr 2024
0:59
What challenges are there in using CAR-T cells for solid tumors?
Leonardo Ferreira • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals